SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,132.81 -382.62
( -0.50%)

Global Indices

Nasdaq

53,423.66 -283.45
(-0.53%)

Dow Jones

7,737.34 -31.37
(-0.40%)

Hang Seng

66,225.50 1,204.56
(1.85%)

Nikkei 225

10,828.70 -2.82
(-0.03%)

Forex

USD-INR

94.48 -0.24
(-0.26%)

EUR-INR

109.71 0.00
(0.00%)

GBP-INR

127.63 -0.19
(-0.15%)

JPY-INR

0.60 0.01
(1.60%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Piramal Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

543635

INE0DK501011

61.1809785

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

PPLPHARMA

36.8

28517.48

EPS(TTM)

Face Value()

Div & Yield %

5.82

Particulars(INCOME)	Mar 2026 ( Cr)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)
Sales Turnover	4782.01	5285.71	4390.11	3443.22	3340.42	2938.81
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	4782.01	5285.71	4390.11	3443.22	3340.42	2938.81
Other Income	662.73	207.35	202.06	341.07	224.79	216.20
Stock Adjustments	138.98	84.57	61.62	-53.31	32.66	-57.86
Total Income	5583.72	5577.63	4653.79	3730.98	3597.87	3097.15
EXPENDITURE :
Raw Materials	2208.88	2330.53	2170.46	1715.17	1594.17	1169.91
Power & Fuel Cost	131.53	131.62	112.89	107.94	83.83	68.08
Employee Cost	744.82	736.19	613.93	548.50	448.03	395.15
Other Manufacturing Expenses	292.60	284.35	251.57	259.29	299.83	252.74
Selling & Administrative Expenses	746.52	746.69	620.04	485.63	427.82	258.75
Miscellaneous Expenses	247.15	100.46	64.92	182.81	59.20	117.39
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	4371.50	4329.84	3833.81	3299.34	2912.88	2262.02
Operating Profit	1212.22	1247.79	819.98	431.64	684.99	835.13
Interest	79.95	114.56	107.10	115.87	57.29	4.71
Gross Profit	1132.27	1133.23	712.88	315.77	627.70	830.42
Depreciation	255.50	222.09	205.26	192.08	165.37	143.64
Profit Before Tax	876.77	911.14	507.62	123.69	462.33	686.78
Tax	114.68	199.44	112.48	38.77	110.82	104.98
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	62.08	20.30	3.92	15.42	-16.03	10.30
Reported Net Profit	700.01	691.40	391.22	69.50	367.54	571.50
Extraordinary Items	-67.52	2.40	3.34	-3.14	-10.64	15.44
Adjusted Net Profit	767.53	689.00	387.88	72.64	378.18	556.06
Adjustment below Net Profit	-13.89	1.05	-3.79	-2.59	31.70	-2.46
P & L Balance brought forward	2037.21	1359.23	971.79	918.28	569.04	0.00
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	18.54	14.47	0.00	13.40	50.00	0.00
P & L Balance carried down	2704.79	2037.21	1359.22	971.79	918.28	569.04
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	1.40	1.10	0.00	5.60	0.00
Dividend Per Share(Rs)	0.00	0.14	0.11	0.00	0.56	0.00
Earnings Per Share-Unit Curr	5.27	5.22	2.96	0.58	3.10	5.75
Earnings Per Share(Adj)-Unit Curr	5.27	5.22	2.96	0.57	3.10	5.75
Book Value-Unit Curr	61.34	56.27	50.74	44.09	43.20	41.23
Book Value(Adj)-Unit Curr	61.34	56.27	50.74	43.06	43.20	41.23

76,132.81 -382.62 ( -0.50%)

53,423.66 -283.45 (-0.53%)

7,737.34 -31.37 (-0.40%)

66,225.50 1,204.56 (1.85%)

10,828.70 -2.82 (-0.03%)

94.48 -0.24 (-0.26%)

109.71 0.00 (0.00%)

127.63 -0.19 (-0.15%)

0.60 0.01 (1.60%)